2 Minnesota companies work on drug-coated balloons

02/15/2009 | Star Tribune (Minneapolis-St. Paul, Minn.)

Lutonix and Possis Medical are separately working to develop drug-coated balloons that could serve as a lower-cost alternative to drug-eluting stents used in treating vascular diseases. Lutonix plans to begin clinical trials in Europe for its device this year and hopes to secure FDA approval by 2014. A spokesman for Possis Medical said the company plans to begin a clinical study of its product in the U.S. in the "near future."

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA